NxStage Medical Inc.
NXTM
NXTM was delisted on the 21st of February, 2019.
114 hedge funds and large institutions have $701M invested in NxStage Medical Inc. in 2014 Q1 according to their latest regulatory filings, with 21 funds opening new positions, 31 increasing their positions, 44 reducing their positions, and 19 closing their positions.
7,689% more call options, than puts
Call options by funds: $2.18M | Put options by funds: $28K
100% more funds holding in top 10
Funds holding in top 10: 3 → 6 (+3)
30% more capital invested
Capital invested by funds: $541M → $701M (+$161M)
11% more first-time investments, than exits
New positions opened: 21 | Existing positions closed: 19
0% more funds holding
Funds holding: 114 → 114 (0)
30% less repeat investments, than reductions
Existing positions increased: 31 | Existing positions reduced: 44
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GGHC
Gilder Gagnon Howe & Co
New York
|
+$56M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$17M |
| 3 |
APG Asset Management
Amsterdam,
Netherlands
|
+$15.8M |
| 4 |
CII
CR Intrinsic Investors
Stamford,
Connecticut
|
+$10.4M |
| 5 |
RG
Redmile Group
San Francisco,
California
|
+$5.21M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DM
Deerfield Management
New York
|
-$23.1M |
| 2 |
WI
WHV Investments
San Francisco,
California
|
-$21.4M |
| 3 |
Norges Bank
Oslo,
Norway
|
-$13.6M |
| 4 |
Wells Fargo
San Francisco,
California
|
-$8.8M |
| 5 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$8.16M |
NXTM Hedge Fund Activity: Q1 2014 in Review
114 of the 3,464 institutional investors tracked by Wall St. Rank reported a position in NxStage Medical Inc. (NXTM) for Q1 2014, worth a combined $701M — up 30% from $541M a quarter earlier.
Buyers outnumbered sellers: 21 funds opened new NXTM positions and 19 closed out — a net gain of 2 holders — while 31 added to existing stakes and 44 trimmed.
The largest buyer was Gilder Gagnon Howe & Co, opening a new position worth an estimated $56M. The largest seller was Deerfield Management, cutting an estimated $23.1M.
- 114 institutional investors held NxStage Medical Inc. (NXTM) as of Q1 2014, unchanged from Q4 2013.
- Funds reported $701M of NxStage Medical Inc. stock for Q1 2014, up 30% quarter-over-quarter.
- 21 funds opened new NxStage Medical Inc. positions in Q1 2014 and 19 closed out, a net change of +2 holders.
- The largest NxStage Medical Inc. buyer in Q1 2014 was Gilder Gagnon Howe & Co, an estimated $56M added.
- The largest NxStage Medical Inc. seller in Q1 2014 was Deerfield Management, an estimated $23.1M sold.
Based on aggregated 13F filings for Q1 2014.